GLOBAL MARKETS FOR PERIPHERAL ENDOVASCULAR AND VASCULAR CLOSURE DEVICES

344 Pages | 171 Exhibits | 2015 Analysis | Forecasts Through 2019 Product Family: Market Reports




OVERVIEW:
Percutaneous transluminal angioplasty will lead the way with double-digit annual growth, driving expansion in U.S. and international markets. Robust market growth is expected for several peripheral endovascular and vascular closure devices on a global basis.

Endovascular therapies have seen rising adoption due to new product introductions, the increasing prevalence of peripheral artery disease, developing healthcare systems in emerging markets, and the desire to utilize minimally invasive interventions. However, clinical challenges and suboptimal long-term outcomes for many patients, primarily from restenosis, have motivated caregivers and manufacturers to explore new devices and techniques.

Efforts to improve outcomes have led to a variety of atherectomy technologies; devices tailored for crossing occluded lesions; stents with specialized or drug-eluting features; embolic protection devices; and, most recently, drug-coated balloons (DCBs). DCBs are expected to spur market growth and account for a rapidly increasing share of the balloon catheters used during percutaneous transluminal angioplasty. While multiple DCBs are available in Europe, only one is currently available in the U.S.-C.R. Bard's Lutonix 035 Drug Coated Balloon PTA Catheter, approved by the FDA in October 2014-although additional product approvals are expected in the coming years.

Technological innovations, growing clinical experience, and shifting healthcare dynamics are expected to profoundly shape the market for peripheral endovascular devices through 2019, as discussed in LSI's timely new analysis. The report covers global markets for atherectomy products, balloon catheters, chronic total occlusion devices, embolic protection devices, peripheral vascular stents, and vascular closure devices. Industry competitors include Aachen Resonance, Abbott Vascular, AccessClosure, AngioScore, Angioslide, Avinger, B. Braun, Bayer Interventional, Baylis Medical, Biotronik, Boston Scientific, C.R. Bard, Cardiovascular Systems, Cook Medical, Covidien, Eurocor, Johnson & Johnson, Medtronic, Minvasys, Natec Medical, Spectranetics, St. Jude Medical, Teleflex Medical, Terumo Interventional Systems, Trireme Medical, Vascular Solutions, Volcano, and W.L. Gore & Associates.

TABLE OF CONTENTS:
ES-1 EXECUTIVE SUMMARY

	ES-1.1 The Global Market for Peripheral Endovascular and Vascular Closure Devices by Type
		ES-1.1.1 Peripheral Endovascular Products
                ES-1.1.2 Vascular Closure Devices

	ES-1.2 The Global Market for Peripheral Endovascular and Vascular Closure Devices by Region
		ES-1.2.1 The U.S.
		ES-1.2.2 Europe
		ES-1.2.3 Asia-Pacific and the Rest-of-the-World

	ES-1.3 Competitive Analysis

	Exhibit ES-1-1: Global Market Forecast for Peripheral Endovascular and Vascular Closure Devices from 2012-2019
	Exhibit ES-1-2: Global Market Forecast for Peripheral Endovascular Products by Type from 2012-2019
	Exhibit ES-1-3: Global Market Forecast for Vascular Closure Devices from 2012-2019
	Exhibit ES-1-4: Global Market Forecast for Peripheral Endovascular and Vascular Closure Devices by Region from 2012-2019
	Exhibit ES-1-5: Global Supplier Shares

1. GLOBAL MARKETS FOR VASCULAR CLOSURE DEVICES - EXECUTIVE SUMMARY

	The global market for vascular closure devices (VCDs), which are often used following arterial puncture for cardiac 
	catheterizations and other procedures, was valued at $706 million in 2013. As analyzed in a new report by Life Science 
	Intelligence, the use of these devices, which include implantables as well as external compression products, will be strongly
	influenced by regional and global trends toward the implementation of cost-effective care as well as the rising use of 
	transradial access-factors which are expected to restrain growth in the market for VCDs at the high end of the price range. 
	This report analyzes and quantifies the key forces driving the global market for VCDs in the U.S., Europe, Asia-Pacific and the  
	rest of the world for the period 2012-2019; some of the major issues covered in the report include:

	•    Trends in arterial access as well as the use of manual 	compression for site closure;
	•    Competitive factors and product introductions;
	•     Procedure volumes;
	•    Critical infrastructure and market metrics; and
	•    Quantitative factors including units, pricing, and product sales.

	1.1 Methods of Vascular Closure: VCDs and Manual Compression 
	1.2 The Global Market by Product Type 
	1.3 The Global Market by Region 
	1.4 Competitive Analysis 

	Exhibit 1-1: Global Vascular Closure Procedures by Type, 2012-2019 
	Exhibit 1-2: The Global Market Forecast for Vascular Closure Devices by Type from 2012-2019 
	Exhibit 1-3: The Global Market Forecast for Vascular Closure Devices by Region from 2012-2019 
	Exhibit 1-4: Global Supplier Shares in 2012 and 2013 

2. GLOBAL MARKETS FOR VASCULAR CLOSURE DEVICES - OVERVIEW
 
	2.1 The Circulatory System 
	2.2 Vascular Anatomy and Physiology 
		2.2.1 Peripheral Arteries 
		2.2.2 Coronary Arteries 
		2.2.3 Arteries of the Head and Neck 
	2.3 Vessel Tissues and Structures 
	2.4 The Wound Healing Process 
		2.4.1 The Inflammatory Phase
		2.4.2 Proliferative Phase 
		2.4.3 Remodeling Phase 
		2.4.4 Factors Affecting Vascular Closure 
	2.5 Conditions Necessitating Vascular Access 
	2.6 Procedural Economics 
		2.6.1 Reimbursement 
			2.6.1.1 Revenue Codes 
			2.6.1.2 DRG Codes 
			2.6.1.3 Economic Justification for Vascular Closure Technologies 

	Exhibit 2-1: Overview of the Circulatory System 
	Exhibit 2-2: Major Arteries in the Cardiovascular System 
	Exhibit 2-3: Types and Functions of the Blood Vessels 
	Exhibit 2-4: Peripheral Arteries and Arteries of the Lower Extremity 
	Exhibit 2-5: Arteries of the Hand, Including the Radial Artery 
	Exhibit 2-6: Arteries of the Head and Neck 
	Exhibit 2-7: Anatomy of the Arteries and Veins
	Exhibit 2-8: The Process of Healing Vessel Wounds 
	Exhibit 2-9: Cardiovascular Pathologies Necessitating Vascular Access
	Exhibit 2-10: Average Medicare Reimbursements in 2014 for Common Catheterization Procedures 

3. GLOBAL MARKETS FOR VASCULAR CLOSURE DEVICES - VASCULAR CLOSURE METHODS AND DEVICES
 
	3.1 Manual Compression 
	3.2 Vascular Closure Devices 
		3.2.1 Implantable Devices 
		3.2.2 External Compression Products 
		3.2.3 Companies and Products

	Exhibit 3-1: Methods of Vascular Closure 
	Exhibit 3-2: Types of Vascular Closure Devices 
	Exhibit 3-3: Clinical Studies Examining Vascular Closure Devices 
	Exhibit 3-4: Selected Vascular Closure Devices in 2014 
	Exhibit 3-5: Abbott Vascular's Vascular Closure Devices 
	Exhibit 3-6: AccessClosure's Mynx Ace Vascular Closure Device 
	Exhibit 3-7: Advanced Vascular Dynamics, Selected Vascular Closure Devices 
	Exhibit 3-8: Cardiva Medical's Catalyst III 
	Exhibit 3-9: Cordis's EXOSEAL Vascular Closure Device 
	Exhibit 3-10: Morris Innovative's FISH Device - Procedural Description 
	Exhibit 3-11: St. Jude Medical's Angio-Seal STS Plus and VIP Vascular Closure Devices 
	Exhibit 3-12: Scion BioMedical's Clo-Sur PLUS P.A.D. 
	Exhibit 3-13: Terumo's TR Band 
	Exhibit 3-14: TZ Medical's Neptune and Neptune Plus 
	Exhibit 3-15: Vascular Solutions' D-Stat 

4. GLOBAL MARKETS FOR VASCULAR CLOSURE DEVICES - PROCEDURE FORECASTS AND MARKET ANALYSIS 

	4.1 The Global Market Forecast for Vascular Closure Devices 
	4.2 The Market by Region 
		4.2.1 The United States 
		4.2.2 Europe 
		4.2.3 Asia-Pacific and the Rest-of-the-World 
		4.2.4 Global Supplier Shares
 
	Exhibit 4-1: Global Vascular Closure Procedures by Type, 2012-2019 
	Exhibit 4-2: The Global Market Forecast for Vascular Closure Devices from 2012-2019
	Exhibit 4-3: The Global Market Forecast for Vascular Closure Devices by Type from 2012-2019 
	Exhibit 4-4: The Global Market Forecast for Vascular Closure Devices by Method of Access from 2012-2019 
	Exhibit 4-5: The Global Market Forecast for Vascular Closure Devices by Region from 2012-2019 
	Exhibit 4-6: U.S. Cardiac Catheterization Procedures by Arterial Access, 2012-2019 
	Exhibit 4-7: Cardiac Catheterizations by Type in the U.S., 2012-2019 
	Exhibit 4-8: Vascular Closure Procedures by Type in the U.S., 2012-2019 
	Exhibit 4-9: The U.S. Market Forecast for Vascular Closure Devices from 2012-2019 
	Exhibit 4-10: The U.S. Market Forecast for Vascular Closure Devices by Type from 2012-2019 
	Exhibit 4-11: The U.S. Market Forecast for Vascular Closure Devices by Method of Access from 2012-2019 
	Exhibit 4-12: European Cardiac Catheterization Procedures by Arterial Access, 2012-2019 
	Exhibit 4-13: Cardiac Catheterizations by Type in Europe, 2012-2019 
	Exhibit 4-14: Vascular Closure Procedures by Type in Europe, 2012-2019 
	Exhibit 4-15: The Market Forecast for Vascular Closure Devices in Europe from 2012-2019 
	Exhibit 4-16: The Market Forecast for Vascular Closure Devices in Europe by Type from 2012-2019 
	Exhibit 4-17: The European Market Forecast for Vascular Closure Devices by Method of Access from 2012-2019 
	Exhibit 4-18: AP & ROW Cardiac Catheterization Procedures by Arterial Access, 2012-2019 
	Exhibit 4-19: AP & ROW Cardiac Catheterizations by Type, 2012-2019 
	Exhibit 4-20: AP & ROW Vascular Closure Procedures by Type, 2012-2019 
	Exhibit 4-21: AP & ROW Market Forecast for Vascular Closure Devices from 2012-2019
	Exhibit 4-22: AP & ROW Market Forecast for Vascular Closure Devices by Type from 2012-2019 
	Exhibit 4-23: The Market Forecast for Vascular Closure Devices by Method of Access in AP & ROW Countries from 2012-2019 
	Exhibit 4-24: Global Supplier Shares in 2012 and 2013 

5. GLOBAL MARKETS FOR VASCULAR CLOSURE DEVICES - COMPANY PROFILES
 
	5.1 Abbott Vascular 
	5.2 AccessClosure (Cardinal Health) 
	5.3 Advanced Vascular Dynamics 
	5.4 Benrikal Services 
	5.5 Cardiva Medical 
	5.6 Cordis Corporation (Johnson & Johnson) 
	5.7 Marine Polymer Technologies 
	5.8 Morris Innovative 
	5.9 Scion BioMedical 
	5.10 St. Jude Medical 
	5.11 Terumo 
	5.12 TZ Medical 
	5.13 Vascular Solutions 

6. GLOBAL MARKETS FOR PERIPHERAL VASCULAR STENT - EXECUTIVE SUMMARY

	The global market for peripheral vascular stents, which was valued at $1.1 billion in 2013, has entered into a dynamic phase which will be characterized by the rising
	prevalence of peripheral artery disease(PAD),growing availability in key regional markets, and the adoption of potentially competitive products, such as drug-coated balloons 
	(DCBs). In the U.S., where DCBs became commercially available in October 2014, the use of stents will continue to be driven by the availability of products that enable 
	treatment for different types of lesions and have indications specific to the target anatomy-e.g., the carotid, femoral, popliteal, iliac, and renal arteries. This should   
	contribute to growing use in patients at high risk for problems following surgical intervention as well as those with applicable lesion profiles. In Europe, where    
	cost-containment efforts are expected to generate price erosion, demographic factors and the use of stents as part of a multi-modal treatment strategy will    
	fuel revenue gains. And in countries in the Asia-Pacific region and the rest of the world, growth will be driven by greater access to care and rising access in 
	underpenetrated markets.

	Critical Issues Covered in this Report:
	•    The competitive landscape for these devices in the U.S. and international markets;
	•    Quantitative factors including units, pricing, and product sales; and
	•    Procedure volumes as well as other key infrastructure and market metrics.

	6.1 The Global Market by Product Type 
	6.2 The Global Market by Region 
	6.3 Competitive Analysis 

	Exhibit 6-1: The Global Market Forecast for Peripheral Vascular Stent Products from 2012-2019 
	Exhibit 6-2: The Global Market Forecast for Peripheral Vascular Stents by Product Type from 2012-2019 
	Exhibit 6-3: The Global Market Forecast for Peripheral Vascular Stents by Region from 2012-2019 
	Exhibit 6-4: Global Supplier Shares in 2012 and 2013 

7. GLOBAL MARKETS FOR PERIPHERAL VASCULAR STENT - OVERVIEW
 
	7.1 The Circulatory System 
	7.2 Vascular Anatomy and Physiology
		7.2.1 Peripheral Arteries 
		7.2.2 Coronary Arteries 
		7.2.3 Arteries of the Head and Neck 
	7.3 Vessel Tissues and Structures 
	7.4 Peripheral Vascular Disease 
	7.5 Prevalence of PAD by Region 
		7.5.1 The United States 
		7.5.2 Europe 
		7.5.3 Asia-Pacific and the Rest of the World 

	Exhibit 7-1: Overview of the Circulatory System 
	Exhibit 7-2: Major Arteries in the Cardiovascular System 
	Exhibit 7-3: Types and Functions of the Blood Vessels 
	Exhibit 7-4: Peripheral Arteries and Arteries of the Lower Extremity 
	Exhibit 7-5: Arteries of the Hand, Including the Radial Artery 
	Exhibit 7-6: Arteries of the Head and Neck 
	Exhibit 7-7: Anatomy of the Arteries and Veins 
	Exhibit 7-8: Prevalence of Peripheral Artery Disease in the U.S. Global Markets for Peripheral Vascular Stent Products in 2014
	Exhibit 7-9: Prevalence of Peripheral Artery Disease in Europe 
	Exhibit 7-10: Prevalence of Peripheral Artery Disease in AP & ROW Countries 

8. GLOBAL MARKETS FOR PERIPHERAL VASCULAR STENT - PERIPHERAL VASCULAR STENT PRODUCTS
 
	8.1 Carotid Artery Stents 
	8.2 Femoropopliteal Stents 
	8.3 Iliac Artery Stents 
	8.4 Renal Artery Stents
 
	Exhibit 8-1: Types of Peripheral Vascular Stents 
	Exhibit 8-2: Selected Recent Studies of Carotid Artery Stenting 
	Exhibit 8-3: Carotid Artery Stents: Selected Products and Suppliers in 2014 
	Exhibit 8-4: Selected Recent Studies of Femoropopliteal Artery Stenting 
	Exhibit 8-5: Femoropopliteal Stents: Selected Products and Suppliers in 2014 
	Exhibit 8-6: Selected Recent Studies of Iliac Artery Stenting 
	Exhibit 8-7: Iliac Artery Stents: Selected Products and Suppliers in 2014 
	Exhibit 8-8: Selected Recent Studies of Renal Artery Stenting 
	Exhibit 8-9: Renal Artery Stents: Selected Products and Suppliers in 2014 

9. GLOBAL MARKETS FOR PERIPHERAL VASCULAR STENT - PROCEDURE FORECASTS & MARKET ANALYSIS

	9.1 The Global Market Forecast for Peripheral Vascular Stent Products 
	9.2 The Market by Region
		9.2.1 The United States 
		9.2.2 Europe 
		9.2.3 Asia-Pacific and the Rest-of-the-World 

	Exhibit 9-1: The Global Market Forecast for Peripheral Vascular Stent Products from 2012-2019 
	Exhibit 9-2: The Global Market Forecast for Peripheral Vascular Stents by Product Type from 2012-2019 
	Exhibit 9-3: The Global Market Forecast for Peripheral Vascular Stents by Region from 2012-2019 
	Exhibit 9-4: The U.S. Market Forecast for Peripheral Vascular Stent Products from 2012-2019 
	Exhibit 9-5: The U.S. Market Forecast for Peripheral Vascular Stents by Product Type from 2012-2019 
	Exhibit 9-6: The U.S. Market Forecast for Carotid Artery Stents from 2012-2019 4-10
	Exhibit 9-7: The U.S. Market Forecast for Femoropopliteal Artery Stents from 2012-2019 
	Exhibit 9-8: The U.S. Market Forecast for Iliac Artery Stents from 2012-2019 
	Exhibit 9-9: The U.S. Market Forecast for Renal Artery Stents from 2012-2019 
	Exhibit 9-10: U.S. Supplier Shares in 2012 and 2013 
	Exhibit 9-11: The European Market Forecast for Peripheral Vascular Stent Products from 2012-2019 
	Exhibit 9-12: The European Market Forecast for Peripheral Vascular Stents by Product Type from 2012-2019 
	Exhibit 9-13: The European Market Forecast for Carotid Artery Stents from 2012-2019 
	Exhibit 9-14: The European Market Forecast for Femoropopliteal Artery Stents from 2012-2019 
	Exhibit 9-15: The European Market Forecast for Iliac Artery Stents from 2012-2019 
	Exhibit 9-16: The European Market Forecast for Renal Artery Stents from 2012-2019 
	Exhibit 9-17: The AP & ROW Market Forecast for Peripheral Vascular Stent Products from 2012-2019 
	Exhibit 9-18: The AP & ROW Market Forecast for Peripheral Vascular Stents by Product Type from 2012-2019 
	Exhibit 9-19: The AP & ROW Market Forecast for Carotid Artery Stents from 2012-2019
	Exhibit 9-20: The AP & ROW Market Forecast for Femoropopliteal Artery Stents from 2012-2019 
	Exhibit 9-21: The AP & ROW Market Forecast for Iliac Artery Stents from 2012-2019 
	Exhibit 9-22: The AP & ROW Market Forecast for Renal Artery Stents from 2012-2019 
	Exhibit 9-23: OUS Supplier Shares in 2012 and 2013 

10. GLOBAL MARKETS FOR PERIPHERAL VASCULAR STENT - COMPANY PROFILES
 
	10.1 Abbott Vascular (Abbott) 
	10.2 Bard Peripheral Vascular (C.R. Bard) 
	10.3 Boston Scientific 
	10.4 Cook Medical (Cook Group) 
	10.5 Cordis Corporation (Johnson & Johnson) 
	10.6 Covidien 
	10.7 Medtronic 
	10.8 W.L. Gore and Associates

11. U.S. MARKETS FOR SPECIALTY PERIPHERAL VASCULAR PRODUCTS - EXECUTIVE SUMMARY

	Atherectomy products, chronic total occlusion devices, balloon catheters, and embolic protection devices accounted for $836 million in U.S. sales during 2013. 
	As discussed in Life Science Intelligence's new report, strong growth is expected in the U.S. market in coming years due to clinical efforts to improve the effectiveness 
	of interventional methods for treating peripheral artery disease (PAD); attempts to refine techniques; and the impact of new products such as drug-coated
	balloons (DCBs), the first of which became commercially available in October 2014. This report examines the forces affecting the U.S. market for these 
	technologies from 2012-2019 and covers key issues, such as:

	•    Quantitative factors including units, pricing, and product sales;
	•    The timing and market introduction of important new technologies;
	•    Procedure volumes as well as other key infrastructure and market metrics; and
	•    The competitive landscape.

	11.1 The U.S. Market by Product Type 
	11.2 Competitive Analysis 

	Exhibit 11-1: Specialty Peripheral Vascular Procedures in the U.S. from 2012-2019 
	Exhibit 11-2: The U.S. Market Forecast for Atherectomy Products, Balloon Catheters, Chronic Total Occlusion Devices, and Embolic Protection Devices from 2012-2019 
	Exhibit 11-3: U.S. Supplier Shares in 2012 and 2013 

12. U.S. MARKETS FOR SPECIALTY PERIPHERAL VASCULAR PRODUCTS - OVERVIEW
 
	12.1 The Circulatory System
	12.2 Vascular Anatomy and Physiology 
		12.2.1 Peripheral Arteries 
		12.2.2 Coronary Arteries 
		12.2.3 Arteries of the Head and Neck 
	12.3 Vessel Tissues and Structures 
	12.4 Peripheral Vascular Disease 
	12.5 Prevalence of PAD by Region 
		12.5.1 The United States 
		12.5.2 Europe 
		12.5.3 Asia-Pacific and the Rest of the World 

	Exhibit 12-1: Overview of the Circulatory System 
	Exhibit 12-2: Major Arteries in the Cardiovascular System 
	Exhibit 12-3: Types and Functions of the Blood Vessels 
	Exhibit 12-4: Peripheral Arteries and Arteries of the Lower Extremity 
	Exhibit 12-5: Arteries of the Hand, Including the Radial Artery 
	Exhibit 12-6: Arteries of the Head and Neck 
	Exhibit 12-7: Anatomy of the Arteries and Veins 
	Exhibit 12-8: Prevalence of Peripheral Artery Disease in the U.S. 
	Exhibit 12-9: Prevalence of Peripheral Artery Disease in Europe 
	Exhibit 12-10: Prevalence of Peripheral Artery Disease in AP & ROW Countries 

13. U.S. MARKETS FOR SPECIALTY PERIPHERAL VASCULAR PRODUCTS - SPECIALTY PERIPHERAL VASCULAR PRODUCTS
 
	13.1 Atherectomy Technologies 
	13.2 Balloon Catheters 
	13.3 Chronic Total Occlusion Devices 
	13.4 Embolic Protection Systems 

	Exhibit 13-1: Specialty Peripheral Vascular Products by Type 
	Exhibit 13-2: Selected Recent Studies of Atherectomy for Peripheral Artery Disease   
	Exhibit 13-3: Atherectomy Devices: Selected Products and Suppliers in 2014 
	Exhibit 13-4: Selected Recent Studies of Balloon Angioplasty for Peripheral Artery Disease 
	Exhibit 13-5: Balloon Catheters: Selected Products and Suppliers in 2014 
	Exhibit 13-6: Selected Recent Studies of Devices Used for Peripheral Artery Chronic Total Occlusion 
	Exhibit 13-7: Devices for Chronic Total Occlusion: Selected Products and Suppliers in 2014 
	Exhibit 13-8: Selected Recent Studies of Devices Used for Embolic Protection during Peripheral Artery Procedures 
	Exhibit 13-9: Embolic Protection Devices: Selected Products and Suppliers in 2014   

14. U.S. MARKETS FOR SPECIALTY PERIPHERAL VASCULAR PRODUCTS - PROCEDURE FORECASTS & MARKET ANALYSIS FOR SPECIALTY PERIPHERAL
 VASCULAR PRODUCTS IN THE U.S.
 
	14.1 Atherectomy Products 
	14.2 Balloon Catheters 
	14.3 Chronic Total Occlusion Devices 
	14.4 Embolic Protection Devices 
	14.5 Competitive Analysis 

	Exhibit 14-1: The U.S. Market Forecast for Specialty Peripheral Vascular Products by Type, 2012-2019 
	Exhibit 14-2: The U.S. Market Forecast for Atherectomy Products from 2012-2019 
	Exhibit 14-3: The U.S. Market Forecast for Atherectomy Devices by Type in 2012, 2013, and 2014 
	Exhibit 14-4: The U.S. Market Forecast for Balloon Catheters from 2012-2019
	Exhibit 14-5: The U.S. Market Forecast for Balloon Catheters by Type from 2012-2019 
	Exhibit 14-6: The U.S. Market Forecast for Chronic Total Occlusion Devices from 2012-2019 
	Exhibit 14-7: The U.S. Market Forecast for Embolic Protection Devices from 2012-2019 
	Exhibit 14-8: The U.S. Market Forecast for Embolic Protection Devices by Type from 2012-2019 
	Exhibit 14-9: U.S. Supplier Shares in 2012 and 2013 

15. U.S. MARKETS FOR SPECIALTY PERIPHERAL VASCULAR PRODUCTS - COMPANY PROFILES
 
	15.1 Abbott Vascular (Abbott) 
	15.2 Bard Peripheral Vascular (C.R. Bard) 
	15.3 Boston Scientific 
	15.4 Cook Medical (Cook Group) 
	15.5 Cordis Corporation (Johnson & Johnson) 
	15.6 Covidien 
	15.7 Medtronic 
	15.8 W.L. Gore and Associates 

16. INTERNATIONAL MARKETS FOR SPECIALTY PERIPHERAL VASCULAR PRODUCTS - EXECUTIVE SUMMARY

	The international market for atherectomy products, chronic total occlusion devices, balloon catheters, and embolic protection devices was valued at $733 million 
	during 2013. This new report from Life Science Intelligence explores the market for these devices in Europe, Asia-Pacific and the rest of the world and analyzes key factors
	influencing the international market, such as how clinical studies in support of product approvals in the U.S. could affect uptake and utilization in Europe; the effects of  
	drug-coated balloons (DCBs) on the interventional market; economic conditions and cost-containment initiatives; and clinical efforts to optimize therapeutic interventions.

	Critical Issues Covered in this Report:
	•    Quantitative factors including units, pricing, and product sales;
	•    The competitive landscape for these devices in international markets; and
	•    Procedure volumes as well as other key infrastructure and market metrics.

	16.1 The International Market by Product Type 
	16.2 The International Market by Region 
		16.2.1 Europe 
		16.2.2 Asia-Pacific and the Rest-of-the-World 
	16.3 Competitive Analysis 

	Exhibit 16-1: Specialty Peripheral Vascular Procedures in OUS Markets from 2012-2019  
	Exhibit 16-2: The OUS Market Forecast for Atherectomy Products, Balloon Catheters, Chronic Total Occlusion Devices, and Embolic Protection Devices from 2012-2019  
	Exhibit 16-3: The European Market Forecast for Atherectomy Products, Balloon Catheters, Chronic Total Occlusion Devices, and Embolic Protection Devices from 2012-2019  
	Exhibit 16-4: The AP & ROW Market Forecast for Specialty Peripheral Vascular Products by Type, 2012-2019 
	Exhibit 16-5: OUS Supplier Shares in 2012 and 2013 

17. INTERNATIONAL MARKETS FOR SPECIALTY PERIPHERAL VASCULAR PRODUCTS - OVERVIEW
 
	17.1 The Circulatory System 
	17.2 Vascular Anatomy and Physiology 
		17.2.1 Peripheral Arteries 
		17.2.2 Coronary Arteries 
		17.2.3 Arteries of the Head and Neck 
	17.3 Vessel Tissues and Structures 
	17.4 Peripheral Vascular Disease 
	17.5 Prevalence of PAD by Region 
		17.5.1 The United States 
		17.5.2 Europe 
		17.5.3 Asia-Pacific and the Rest of the World 

	Exhibit 17-1: Overview of the Circulatory System 
	Exhibit 17-2: Major Arteries in the Cardiovascular System 
	Exhibit 17-3: Types and Functions of the Blood Vessels 
	Exhibit 17-4: Peripheral Arteries and Arteries of the Lower Extremity 
	Exhibit 17-5: Arteries of the Hand, Including the Radial Artery 
	Exhibit 17-6: Arteries of the Head and Neck 
	Exhibit 17-7: Anatomy of the Arteries and Veins 
	Exhibit 17-8: Prevalence of Peripheral Artery Disease in the U.S. 
	Exhibit 17-9: Prevalence of Peripheral Artery Disease in Europe 
	Exhibit 17-10:  Prevalence of Peripheral Artery Disease in AP & ROW Countries 

18. INTERNATIONAL MARKETS FOR SPECIALTY PERIPHERAL VASCULAR PRODUCTS - SPECIALTY PERIPHERAL VASCULAR PRODUCTS
 
	18.1 Atherectomy Technologies 
	18.2 Balloon Catheters 
	18.3 Chronic Total Occlusion Devices 
	18.4 Embolic Protection Systems

	Exhibit 18-1: Specialty Peripheral Vascular Products by Type 
	Exhibit 18-2: Selected Recent Studies of Atherectomy for Peripheral Artery Disease   
	Exhibit 18-3: Atherectomy Devices: Selected Products and Suppliers in 2014 
	Exhibit 18-4: Selected Recent Studies of Balloon Angioplasty for Peripheral Artery Disease  
	Exhibit 18-5: Balloon Catheters: Selected Products and Suppliers in 2014 
	Exhibit 18-6: Selected Recent Studies of Devices Used for Peripheral Artery Chronic Total Occlusion 
	Exhibit 18-7: Devices for Chronic Total Occlusion: Selected Products and Suppliers in 2014  
	Exhibit 18-8: Selected Recent Studies of Devices Used for Embolic Protection during Peripheral Artery Procedures 
	Exhibit 18-9: Embolic Protection Devices: Selected Products and Suppliers in 2014   

19. INTERNATIONAL MARKETS FOR SPECIALTY PERIPHERAL VASCULAR PRODUCTS - PROCEDURE FORECASTS & MARKET ANALYSIS
 
	19.1 The European Market Forecast for Specialty Peripheral Vascular Products 
		19.1.1 Atherectomy Products 
		19.1.2 Balloon Catheters 
		19.1.3 Chronic Total Occlusion Devices 
		19.1.4 Embolic Protection Devices 
	19.2 The AP & ROW Market Forecast for Specialty Peripheral Vascular Products 
		19.2.1 Atherectomy Products 
		19.2.2 Balloon Catheters 
		19.2.3 Chronic Total Occlusion Devices 
		19.2.4 Embolic Protection Devices 
	19.3 Competitive Analysis 

	Exhibit 19-1: The OUS Market Forecast for Specialty Peripheral Vascular Products by Type, 2012-2019 
	Exhibit 19-2: The OUS Market Forecast for Specialty Peripheral Vascular Products by Region, 2012-2019 
	Exhibit 19-3: The European Market Forecast for Specialty Peripheral Vascular Products by Type, 2012-2019 
	Exhibit 19-4: The European Market Forecast for Atherectomy Products from 2012-2019  
	Exhibit 19-5: The European Market Forecast for Atherectomy Devices by Type in 2012, 2013, and 2014 
	Exhibit 19-6: The European Market Forecast for Balloon Catheters from 2012-2019   
	Exhibit 19-7: The European Market Forecast for Balloon Catheters by Type from 2012-2019  
	Exhibit 19-8: The European Market Forecast for Chronic Total Occlusion Devices from 2012-2019 
	Exhibit 19-9: The European Market Forecast for Embolic Protection Devices from 2012-2019 
	Exhibit 19-10: The European Market Forecast for Embolic Protection Devices by Type from 2012-2019 
	Exhibit 19-11: The AP & ROW Market Forecast for Specialty Peripheral Vascular Products by Type, 2012-2019 
	Exhibit 19-12: The AP & ROW Market Forecast for Atherectomy Products from 2012-2019  
	Exhibit 19-13: The AP & ROW Market Forecast for Atherectomy Devices by Type in 2012, 2013, and 2014 
	Exhibit 19-14: The AP & ROW Market Forecast for Balloon Catheters from 2012-2019  
	Exhibit 19-15: The AP & ROW Market Forecast for Chronic Total Occlusion Devices from 2012-2019  
	Exhibit 19-16: The AP & ROW Market Forecast for Embolic Protection Devices from 2012-2019  
	Exhibit 19-17: The AP & ROW Market Forecast for Embolic Protection Devices by Type from 2012-2019                  

20. INTERNATIONAL MARKETS FOR SPECIALTY PERIPHERAL VASCULAR PRODUCTS - COMPANY PROFILES
 
	20.1 Abbott Vascular (Abbott) 
	20.2 Bard Peripheral Vascular (C.R. Bard) 
	20.3 Boston Scientific 
	20.4 Cook Medical (Cook Group) 
	20.5 Cordis Corporation (Johnson & Johnson) 
	20.6 Covidien 
	20.7 Medtronic
        20.8 Straub Medical 
	20.9 W.L. Gore and Associates
 


COMPANIES COVERED:

  1. Aachen Resonance
  2. Abbott Vascular (Abbott)
  3. AccessClosure/Cardinal Health
  4. Advanced Vascular Dynamics
  5. AngioScore
  6. Angioslide
  7. Avinger
  8. B. Braun
  9. Bard Peripheral Vascular (C.R. Bard)
  10. Bayer Interventional
  11. Baylis Medical
  12. Benrikal Services
  13. Biotronik
  14. Boston Scientific
  15. Cardiovascular Systems
  16. Cardiva Medical
  17. Cook Medical (Cook Group)
  18. Cordis Corporation (Johnson & Johnson)
  19. Eurocor
  20. ev3/Covidien
  21. Marine Polymer Technologies
  22. Medtronic
  23. Minvasys
  24. Morris Innovative
  25. Natec Medical
  26. Rex Medical
  27. Roxwood Medical
  28. Scion BioMedical
  29. Spectranetics
  30. St. Jude Medical
  31. Straub Medical
  32. Teleflex Medical
  33. Terumo
  34. Terumo Interventional Systems
  35. Trireme Medical
  36. TZ Medical
  37. Vascular Solutions
  38. Volcano
  39. W.L. Gore and Associates
Contact Us

Need help finding medtech research? Let us help you!